Media Archive 2005

Cell research aims at cancer vaccine, Media Release, 22 September 2005. The development of a cancer vaccine is the ultimate goal of an ambitious new research project at the Bio21 Molecular Science and Biotechnology Institute at the University of Melbourne.

Victoria Prize awarded to top dental scientist, Media Release, 11 August 2005. Prominent University of Melbourne dental scientist Professor Eric Reynolds was today awarded the Victoria Prize for his groundbreaking research into oral diseases and the prevention of tooth decay.

$21 million awarded for x-ray science and free-radical research, Media Release, 16 June 2005. X-ray science and free-radical chemistry will be the focus of two new University of Melbourne-led Centres of Excellence that will receive $21 million in funding from the Australian government.

University opens $100 million biotech R&D facility, Media Release, 9 June 2005. The Bio21 Molecular Science and Biotechnology Institute - the University of Melbourne's $100 million contribution to Australia's biotechnology R & D effort - was today officially opened by the Premier of Victoria, Mr Steve Bracks.

Deadly parasites reveal Achilles' heel, Media Release, 8 June 2005. Many parasites are hard to fight because their cells are so similar to ours that the drugs we use kill our cells too. Now, Bio21 Institute researchers at the University of Melbourne have discovered a potential Achilles' heel which could allow us to take on the parasites that cause millions of human deaths worldwide from leishmaniasis and tuberculosis, without the cost to our own cells.

From frog venom to solar panels, Media Release, 8 June 2005. Solar panels you can paint on the wall - that's one of the dreams of one of the Bio21 Institute's star recruits, organic chemist Professor Andrew Holmes.

Resistance is futile - new hope in the fight against insect pests, Media Release, 8 June 2005. A PhD student has identified a gene which may help create an early warning system for resistance to insecticides. The discovery was announced at the opening of the University of Melbourne's Bio21 Institute today.